Compositions and methods for propogating insulin and glucagon secreting cells from type 1 diabetic pancreatic tissue and therapeutic uses thereof
AssigneeImagine Pharma LLC
InventorsNGOC THAI, JONATHAN POLLETT, RITA BOTTINO
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compositions and methods for generating compositions comprising cell-based therapeutics useful for treating pancreatic disorders, including Type 1 diabetes.
Claims20
A composition comprising an insulin and glucagon secreting cell population generated from non-insulin secreting pancreatic cells collected from a Type 1 diabetic donor pancreas, a pancreatitis donor pancreas, or a combination thereof.
A method for preparing a composition comprising an insulin and glucagon secreting cell population, which comprises:
- treating in vitro a population of non-insulin secreting Type 1 diabetic pancreatic cells with an islet cell culture medium comprising a base medium and an effective amount of a polypeptide comprising an amino acid sequence having at least 80% sequence identity to the amino acid sequence set forth in SEQ ID NO. 1 or 2, a polypeptide comprising SEQ ID NO. 1, an active fragment of SEQ ID NO. 1, SEQ ID NO. 2, an active fragment of SEQ ID NO. 2, or a combination thereof.
A composition comprising an insulin and glucagon secreting cell population generated from non-insulin secreting pancreatic cells collected from a Type 1 diabetic donor pancreas for use in the treatment of Type 1 diabetes, pancreatitis, or a combination thereof.
Dependencies are inferred from the claim text.